+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Zika Vaccine"

Global Preventive Vaccines Market, 2020-2030 - Product Thumbnail Image

Global Preventive Vaccines Market, 2020-2030

  • Report
  • April 2020
  • 248 Pages
  • Global
From
Human Vaccines - Global Strategic Business Report - Product Thumbnail Image

Human Vaccines - Global Strategic Business Report

  • Report
  • April 2024
  • 262 Pages
From
From
From
Vaccinations - Product Thumbnail Image

Vaccinations

  • Book
  • November 2018
  • 7 Results (Page 1 of 1)
Loading Indicator

The Zika Vaccine market is a subset of the larger Vaccines market. It is focused on the development of vaccines to protect against the Zika virus, a mosquito-borne virus that can cause severe birth defects in newborns. Vaccines are typically developed through a combination of public and private sector research and development, and the Zika Vaccine market is no exception. Vaccines are typically tested in clinical trials to ensure safety and efficacy before being approved for use. The Zika Vaccine market is highly competitive, with a number of companies vying for a share of the market. Companies in the market include Sanofi Pasteur, GlaxoSmithKline, Merck, Johnson & Johnson, and Takeda Pharmaceuticals. These companies are actively researching and developing vaccines to protect against the Zika virus, with some already in clinical trials. Show Less Read more